Lets new over-the-counter drugs get approved faster for public health benefits.
This bill would create a faster way for certain new over-the-counter drugs to get approved by the Food and Drug Administration (FDA). It would allow drug companies to ask the FDA to speed up the review of nonprescription drugs that offer important public health benefits. This could potentially bring new treatments to consumers sooner.
Today, there is no specific fast-track approval process for over-the-counter drugs that could offer major public health benefits. This bill would create a new system, letting the Secretary of Health and Human Services designate certain nonprescription drugs as 'priority' and speed up their development and review, potentially bringing them to market faster for consumers.
HR 9774 · 119th Congress · July 20, 2026 · AI Summary by gemini-2.5-flash · 10/10
Sign in to see your representatives' phone numbers